Our Team   

We boast extensive experience in drug discovery, CMC development, translational medicine, and regulatory trial, with in-depth expertise in global regulatory frameworks and quality systems. Adhering to a patient-centric approach and guided by science and efficiency, we are committed to translating innovative concepts into accessible clinical therapies.   

Company Profile

InnovaRadi is a vertically integrated radiopharmaceutical therapy company dedicated to developing precision oncology drugs based on alpha-emitting radionuclides. Our mission is to leverage breakthrough technologies to advance the clinical application of the alpha radionuclide astatine-211 (²¹¹At) in targeted tumor therapy, and accelerate the translation of innovative drugs from the laboratory to effective treatment solutions that benefit patients.   

Advantages of ²¹¹At   

With its simple decay profile, high linear energy transfer (LET), short range, and potent cytotoxic effect, ²¹¹At demonstrates unprecedented potential in eradicating minimal residual disease, drug-resistant cells, and metastatic lesions. We focus on labeling such radionuclide with highly specific targeting molecules to develop innovative drugs with both high selectivity and low toxicity, providing truly personalized and precise cancer treatment regimens for patients.   

Vertically Integrated Layout   

Our business scope covers:   

- R&D of radiopharmaceuticals and carrier molecules   

- Drug conjugation and formulation process platform   

- Translational medicine and IND enabling

- Clinical research and commercial operation systems   

Strategic Collaboration   

We maintain strategic cooperation with leading global research institutions, medical centers, and industry partners to jointly accelerate the clinical translation of innovative therapies, enabling more patients to benefit at an early stage.   

Future Outlook   

Continue to focus on the ²¹¹At therapy field, constantly enrich the innovative pipeline. We aim to set a new industry benchmark for cancer treatment and help patients worldwide regain health and a new lease on life.